214 related articles for article (PubMed ID: 31221690)
1. Effects of neurofeedback versus methylphenidate for the treatment of ADHD: systematic review and meta-analysis of head-to-head trials.
Yan L; Wang S; Yuan Y; Zhang J
Evid Based Ment Health; 2019 Aug; 22(3):111-117. PubMed ID: 31221690
[TBL] [Abstract][Full Text] [Related]
2. Effects of neurofeedback versus methylphenidate for the treatment of attention-deficit/hyperactivity disorder protocol for a systematic review and meta-analysis of head-to-head trials.
Yan L; Zhang J; Yuan Y; Cortese S
Medicine (Baltimore); 2018 Sep; 97(39):e12623. PubMed ID: 30278582
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD.
Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
J Child Psychol Psychiatry; 2016 May; 57(5):633-44. PubMed ID: 26748531
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder.
Sudnawa KK; Chirdkiatgumchai V; Ruangdaraganon N; Khongkhatithum C; Udomsubpayakul U; Jirayucharoensak S; Israsena P
Pediatr Int; 2018 Sep; 60(9):828-834. PubMed ID: 29931709
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
[TBL] [Abstract][Full Text] [Related]
6. Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD.
Bioulac S; Purper-Ouakil D; Ros T; Blasco-Fontecilla H; Prats M; Mayaud L; Brandeis D
BMC Psychiatry; 2019 Aug; 19(1):237. PubMed ID: 31370811
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit/Hyperactivity Disorder.
Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
J Child Adolesc Psychopharmacol; 2016 May; 26(4):344-53. PubMed ID: 26771913
[TBL] [Abstract][Full Text] [Related]
9. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
10. Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial.
Purper-Ouakil D; Blasco-Fontecilla H; Ros T; Acquaviva E; Banaschewski T; Baumeister S; Bousquet E; Bussalb A; Delhaye M; Delorme R; Drechsler R; Goujon A; Häge A; Kaiser A; Mayaud L; Mechler K; Menache C; Revol O; Tagwerker F; Walitza S; Werling AM; Bioulac S; Brandeis D
J Child Psychol Psychiatry; 2022 Feb; 63(2):187-198. PubMed ID: 34165190
[TBL] [Abstract][Full Text] [Related]
11. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Epstein T; Patsopoulos NA; Weiser M
Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
[TBL] [Abstract][Full Text] [Related]
12. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
Lam AP; Matthies S; Graf E; Colla M; Jacob C; Sobanski E; Alm B; Rösler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Müller HHO; Lücke C; Huss M; Jans T; Berger M; Tebartz van Elst L; Philipsen A;
JAMA Netw Open; 2019 May; 2(5):e194980. PubMed ID: 31150084
[TBL] [Abstract][Full Text] [Related]
13. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials.
Cortese S; Ferrin M; Brandeis D; Holtmann M; Aggensteiner P; Daley D; Santosh P; Simonoff E; Stevenson J; Stringaris A; Sonuga-Barke EJ;
J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):444-55. PubMed ID: 27238063
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Otasowie J; Castells X; Ehimare UP; Smith CH
Cochrane Database Syst Rev; 2014 Sep; (9):CD006997. PubMed ID: 25238582
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
[TBL] [Abstract][Full Text] [Related]
16. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
[TBL] [Abstract][Full Text] [Related]
17. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.
Castells X; Blanco-Silvente L; Cunill R
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D
PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials.
Liu Q; Zhang H; Fang Q; Qin L
J Clin Exp Neuropsychol; 2017 Nov; 39(9):854-865. PubMed ID: 28052720
[TBL] [Abstract][Full Text] [Related]
20. Behavioral Effects of Neurofeedback Compared to Stimulants and Physical Activity in Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial.
Geladé K; Janssen TW; Bink M; van Mourik R; Maras A; Oosterlaan J
J Clin Psychiatry; 2016 Oct; 77(10):e1270-e1277. PubMed ID: 27631143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
